Molecular Response, a privately held molecular diagnostic services company based in San Diego, has named Cyrus Mirsaidi as CEO, according to a statement from the company. The molecular diagnostics startup identifies only the San Diego-based Biotech Investment Group as an investor on its website. Molecular Response says it was founded to reduce risk and increase the efficacy of therapeutic drug development for its partners by identifying clinically relevant biological markers. The company’s executive chairman, Masood Tayebi, also is a managing partner at the Biotech Investment Group.
By posting a comment, you agree to our terms and conditions.